Centerpoint Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Centerpoint Advisory Group's LLY Position: Q3 2026 in Review
Centerpoint Advisory Group reduced its Eli Lilly (LLY) stake by 4.3% in Q3 2026, selling an estimated $18.9K and leaving 354 shares worth $410K. The position accounts for 0.25% of the portfolio, ranked #70.
Centerpoint Advisory Group first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $545K in Q1 2025. 4,594 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Centerpoint Advisory Group held 354 shares of Eli Lilly worth $410K as of Q3 2026.
- Centerpoint Advisory Group sold 16 Eli Lilly shares in Q3 2026, an estimated $18.9K.
- Eli Lilly made up 0.25% of Centerpoint Advisory Group's portfolio in Q3 2026, its #70 holding.
- Centerpoint Advisory Group first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- Centerpoint Advisory Group's Eli Lilly position peaked at $545K in Q1 2025.
- 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Centerpoint Advisory Group's 13F filing for Q3 2026, filed 23 Oct 2026.